written on 01.05.2009

Resources > Country Reports > South Korea

main_img

Moderna / Bullish Bancel “Not Losing Sleep” over COVID-19 Vaccine IP Waiver, Looking to mRNA’s Future in Rare Diseases & Oncology

The day the Biden administration announced its support for the waiver of IP rights for COVID-19 vaccines,…

Japan / Takeda’s Revenue up 5x; First Domestic COVID-19 Vaccine; Industry Opposes IP Waiver

The latest from Japanese pharma, including Takeda’s big profit jump, British Linepharma’s quest to get the…

Switzerland / Lonza Goes Big with Investments in Biologics, ADCs & Vaccines Manufacturing

In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in…